Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

(±)-NBI 74330

Name (±)-NBI 74330
Supplier R&D Systems
Catalog 4528
Prices $265.00
Sizes 10 mg
Cas Number 473722-68-8
Chemical Name N-1-[(3-4(-Ethoxyphenyl)-3,4-dihydro-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-4-fluoro-N-(3-pyridinylmethyl)-3-(trifluoromethyl)benzeneacetamide
Formula C32H27F4N5O3
Molecular Weight 605.58
Purity >98%
Supplier Page Shop

Product References

Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and - Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and

Storelli S, Verzijl D, Al-Badie J, Elders N, Bosch L, Timmerman H, Smit MJ, De Esch IJ, Leurs R. Arch Pharm (Weinheim). 2007 Jun;340(6):281-91.

Noncompetitive antagonism and inverse agonism as mechanism of action of - Noncompetitive antagonism and inverse agonism as mechanism of action of

Verzijl D, Storelli S, Scholten DJ, Bosch L, Reinhart TA, Streblow DN, Tensen CP, Fitzsimons CP, Zaman GJ, Pease JE, de Esch IJ, Smit MJ, Leurs R. J Pharmacol Exp Ther. 2008 May;325(2):544-55.

Pharmacological characterization of CXC chemokine receptor 3 ligands and a small - Pharmacological characterization of CXC chemokine receptor 3 ligands and a small

Heise CE, Pahuja A, Hudson SC, Mistry MS, Putnam AL, Gross MM, Gottlieb PA, Wade WS, Kiankarimi M, Schwarz D, Crowe P, Zlotnik A, Alleva DG. J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71. Epub 2005 Mar 10.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved